Article: The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas.
2020 Volume 8, Page(s) 178
Abstract: The RNA-guided clustered regularly interspaced palindromic repeats (CRISPR)/associated nuclease 9 (Cas9)-based genome editing technology has increasingly become a recognized method for translational research. In oncology, the ease and versatility of ... ...
Abstract | The RNA-guided clustered regularly interspaced palindromic repeats (CRISPR)/associated nuclease 9 (Cas9)-based genome editing technology has increasingly become a recognized method for translational research. In oncology, the ease and versatility of CRISPR/Cas9 has made it possible to obtain many results in the identification of new target genes and in unravel mechanisms of resistance to therapy. The majority of the studies have been made on adult tumors so far. In this mini review we present an overview on the major aspects of CRISPR/Cas9 technology with a focus on a group of rare pediatric malignancies, soft tissue sarcomas, on which this approach is having promising results. |
---|---|
Language | English |
Publishing date | 2020-03-13 |
Publishing country | Switzerland |
Document type | Journal Article ; Review |
ZDB-ID | 2711776-5 |
ISSN | 2296-2646 |
ISSN | 2296-2646 |
DOI | 10.3389/fchem.2020.00178 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.